|
|
|
|
|
|
|
The 1st and 2nd rounds of equity-fund raising for the company have been completed in the Tokyo market through Japanese Venture Capital companies largely. The company has issued around 30% new shares at approximately 500 million yen to Venture Capital companies. |
|
|
Nippon Medical Research, Inc. |